Biomerica, Inc.
BMRA · NASDAQ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 18.87M | 2.98M | -4.53M | -4.53M | -0.36 |
| 2023 FY | 5.34M | 446.00K | -7.22M | -7.14M | -0.50 |
| 2024 FY | 5.42M | 611.00K | -6.37M | -5.98M | -0.36 |
| 2025 FY | 5.31M | 498.00K | -5.14M | -4.97M | -2.16 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 11.37M | 3.05M | 5.92M | 1.38M | 8.32M |
| 2023 FY | 14.45M | 2.73M | 9.72M | 1.08M | 11.72M |
| 2024 FY | 9.25M | 2.66M | 4.17M | 785.00K | 6.59M |
| 2025 FY | 5.95M | 1.84M | 2.40M | 458.00K | 4.11M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | -480.53K | -170.34K | -650.87K | — | 1.72M |
| 2023 FY | -5.47M | -78.00K | -5.55M | — | 3.80M |
| 2024 FY | -5.36M | -115.00K | -5.48M | — | -5.55M |
| 2025 FY | -3.84M | -37.00K | -3.88M | — | -1.77M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 354.85M | 350.31M | — | — | — |
| 2023 FY | 155.13M | 146.49M | — | — | — |
| 2024 FY | 78.05M | 74.67M | — | — | — |
| 2025 FY | 7.01M | 5.07M | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q4 | 749.00K | -244.00K | -1.56M | -1.54M | -0.16 |
| 2026 Q1 | 1.38M | 424.00K | -1.12M | 2.00K | 0.00 |
| 2026 Q2 | 1.21M | 51.00K | -1.37M | -1.32M | -0.45 |
| 2026 Q3 | 987.00K | -44.00K | -1.30M | -1.31M | -0.44 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q4 | 5.95M | 1.84M | 2.40M | 458.00K | 4.11M |
| 2026 Q1 | 6.85M | 1.70M | 3.05M | 373.00K | 5.16M |
| 2026 Q2 | 6.03M | 1.60M | 2.54M | 284.00K | 4.44M |
| 2026 Q3 | 4.88M | 1.56M | 1.34M | 193.00K | 3.32M |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q4 | -661.00K | — | -661.00K | — | -658.00K |
| 2026 Q1 | -268.00K | — | -268.00K | — | 617.00K |
| 2026 Q2 | -991.00K | 37.00K | -954.00K | — | -473.00K |
| 2026 Q3 | -1.25M | -37.00K | -1.29M | — | -1.21M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q4 | 29.61M | 27.67M | — | — | — |
| 2026 Q1 | 8.26M | 5.58M | — | — | — |
| 2026 Q2 | 6.57M | 4.31M | — | — | — |
| 2026 Q3 | 6.26M | 5.12M | — | — | — |